title: Azacitidine.
authors.affiliation: Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. jpissa@mdanderson.org <jpissa@mdanderson.org>
authors.forename: Jean-Pierre J
authors.initials: JP
authors.lastname: Issa
authors.forename: Hagop M
authors.initials: HM
authors.lastname: Kantarjian
authors.forename: Peter
authors.initials: P
authors.lastname: Kirkpatrick
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D001374:Azacitidine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D019175:DNA Methylation / Q000187:drug effects*; D015195:Drug Design; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000378:metabolism
chemical_list: D000964:Antimetabolites, Antineoplastic; D001374:Azacitidine